Arcturus Therapeutics (ARCT) Stock Chart & Stock Price History $13.64 +0.02 (+0.11%) As of 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock Arcturus Therapeutics Stock Price Performance The Arcturus Therapeutics (ARCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 37.82%, with a year-to-date return of -19.65%. In the past month, the stock has increased 4.88%, reflecting recent market activity. As of the latest close, Arcturus Therapeutics traded at $13.62 with a market cap of $369.37 million and volume of 590,311 shares. Five years ago, the stock traded at $46.56, representing a 70.72% decrease over that period. At the time, it had a market cap of $929.77 million and a volume of 731,933 shares. Receive ARCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.29%1 Month Performance+4.88%3 Month Performance+43.83%Year-To-Date Performance-19.65%1 Year Performance-37.82%5 Year Performance-70.72% ARCT Stock Chart for Thursday, July, 3, 2025 ARCT Chart by TradingView Arcturus Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$13.62$13.64+0.11%$13.94$13.44172,653 shs$369.78 million07/02/2025$12.99$13.62+4.85%$14.09$12.98590,311 shs$369.37 million07/01/2025$13.01$12.99-0.15%$13.74$12.65489,341 shs$352.29 million06/30/2025$13.33$13.01-2.40%$14.58$12.97656,158 shs$352.83 million06/27/2025$14.41$13.33-7.49%$14.53$13.001.20 million shs$361.51 million06/26/2025$13.95$14.41+3.30%$14.75$13.74517,333 shs$390.81 million06/25/2025$13.41$13.95+4.03%$14.01$13.03481,996 shs$378.32 million06/24/2025$12.51$13.41+7.19%$13.55$12.52353,313 shs$363.68 million06/23/2025$12.29$12.51+1.79%$12.52$12.03306,107 shs$339.27 million06/20/2025$12.35$12.29-0.49%$12.57$12.07645,432 shs$333.31 million Get the Latest News and Ratings for ARCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$12.35$12.35$12.98$12.10377,342 shs$334.93 million06/18/2025$12.28$12.35+0.57%$12.98$12.10377,342 shs$334.93 million06/17/2025$12.87$12.28-4.58%$12.99$12.25321,536 shs$333.05 million06/16/2025$12.38$12.87+3.96%$13.42$12.25436,301 shs$349.05 million06/13/2025$12.64$12.38-2.06%$12.59$12.01433,067 shs$335.76 million06/12/2025$12.44$12.64+1.61%$12.87$12.07313,202 shs$342.81 million06/11/2025$12.90$12.44-3.57%$13.32$12.42344,978 shs$337.39 million06/10/2025$12.54$12.90+2.87%$13.62$12.72657,898 shs$349.86 million06/09/2025$12.79$12.54-1.95%$13.18$12.30358,941 shs$340.10 million06/06/2025$11.91$12.79+7.39%$12.93$12.05550,246 shs$346.88 million06/05/2025$12.26$11.91-2.85%$12.38$11.83474,520 shs$323.01 million06/04/2025$13.00$12.26-5.69%$13.27$12.26343,573 shs$332.50 million06/03/2025$12.81$13.00+1.48%$13.25$12.72778,576 shs$352.57 million06/02/2025$12.63$12.81+1.43%$13.60$12.47716,662 shs$347.42 million Related Companies Vera Therapeutics Stock Price Chart Ocular Therapeutix Stock Price Chart Travere Therapeutics Stock Price Chart BGM Group Stock Price Chart Structure Therapeutics Stock Price Chart CureVac Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Dyne Therapeutics Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Niagen Bioscience Stock Price Chart Receive ARCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arcturus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARCT) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcturus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
